These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 3950674)

  • 1. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
    Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini PL; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
    J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
    Lavey RS; Eby NL; Prosnitz LR
    Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
    Tester WJ; Kinsella TJ; Waller B; Makuch RW; Kelley PA; Glatstein E; DeVita VT
    J Clin Oncol; 1984 Jul; 2(7):762-9. PubMed ID: 6547479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease.
    Mendenhall NP; Shuster JJ; Million RR
    Radiother Oncol; 1989 Mar; 14(3):219-29. PubMed ID: 2710953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
    J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
    J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
    Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
    J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
    Mauch PM; Canellos GP; Rosenthal DS; Hellman S
    J Clin Oncol; 1985 Apr; 3(4):501-5. PubMed ID: 3872348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980).
    Cornbleet MA; Vitolo U; Ultmann JE; Golomb HM; Oleske D; Griem ML; Ferguson DJ; Miller JB
    J Clin Oncol; 1985 Jun; 3(6):758-68. PubMed ID: 4009215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second cancers after treatment for Hodgkin's disease.
    Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
    N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.
    Henry-Amar M
    NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
    Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
    J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.